Mark Sullivan

2.5k total citations
44 papers, 1.2k citations indexed

About

Mark Sullivan is a scholar working on Epidemiology, Infectious Diseases and Aerospace Engineering. According to data from OpenAlex, Mark Sullivan has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Aerospace Engineering. Recurrent topics in Mark Sullivan's work include Hepatitis B Virus Studies (8 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis C virus research (6 papers). Mark Sullivan is often cited by papers focused on Hepatitis B Virus Studies (8 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis C virus research (6 papers). Mark Sullivan collaborates with scholars based in United States, Australia and United Kingdom. Mark Sullivan's co-authors include Carol Brosgart, Peter Buggisch, K. Kleber, Ramin Ebrahimi, Marion G. Peters, Paul Martin, S. Xiong, DF Gray, Kris V. Kowdley and Marc Bourlière and has published in prestigious journals such as Gastroenterology, PLoS ONE and The Journal of Urology.

In The Last Decade

Mark Sullivan

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sullivan United States 12 778 699 259 169 115 44 1.2k
Sun Pyo Hong South Korea 21 860 1.1× 687 1.0× 260 1.0× 167 1.0× 54 0.5× 65 1.2k
Christian M. Lange Germany 24 969 1.2× 1.1k 1.6× 197 0.8× 420 2.5× 106 0.9× 86 2.0k
Marija Zeremski United States 22 774 1.0× 870 1.2× 151 0.6× 600 3.6× 236 2.1× 45 1.8k
Hussein Hassan Aly Japan 16 541 0.7× 503 0.7× 128 0.5× 310 1.8× 70 0.6× 37 995
Soo Aleman Sweden 21 1.2k 1.5× 1.0k 1.5× 357 1.4× 144 0.9× 137 1.2× 121 1.9k
Virginie Morel France 16 309 0.4× 365 0.5× 122 0.5× 110 0.7× 132 1.1× 41 780
Mariantonietta Pisaturo Italy 26 1.4k 1.7× 1.3k 1.8× 257 1.0× 137 0.8× 109 0.9× 102 1.8k
Enea Spada Italy 26 1.2k 1.5× 1.4k 2.0× 294 1.1× 117 0.7× 146 1.3× 62 1.8k

Countries citing papers authored by Mark Sullivan

Since Specialization
Citations

This map shows the geographic impact of Mark Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sullivan more than expected).

Fields of papers citing papers by Mark Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sullivan. The network helps show where Mark Sullivan may publish in the future.

Co-authorship network of co-authors of Mark Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sullivan. A scholar is included among the top collaborators of Mark Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sullivan. Mark Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amerine, Lindsey B., et al.. (2025). ASHP Statement on the Roles and Responsibilities of the Pharmacy Executive. American Journal of Health-System Pharmacy. 82(23). e1020–e1022.
2.
Sullivan, Mark. (2025). Rethinking pharmaceutical development: A not-for-profit model to address global health inequities. Future Healthcare Journal. 12(2). 100255–100255. 1 indexed citations
3.
Wood, Nolan, Sally Kinrade, Mark Sullivan, et al.. (2024). The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. PLoS neglected tropical diseases. 18(8). e0012351–e0012351. 2 indexed citations
4.
5.
Williams, J. P., B. T. Greenhagen, K. A. Bennett, et al.. (2021). Temperatures of the Lacus Mortis Region of the Moon. Earth and Space Science. 9(2). 4 indexed citations
6.
Olliaro, Piero, Annette C. Kuesel, Christine Halleux, Mark Sullivan, & John C. Reeder. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. PLoS neglected tropical diseases. 12(11). e0006837–e0006837. 17 indexed citations
7.
Anderson, Robin L., Juliana Callaghan, R. Charles Coombes, et al.. (2018). A framework for the development of effective anti-metastatic agents. Nature Reviews Clinical Oncology. 16(3). 185–204. 245 indexed citations
8.
Justice, C. O., E. Vermote, Varaprasad Bandaru, et al.. (2016). Transitioning from MODIS to S-NPP VIIRS data for Agricultural Monitoring. AGU Fall Meeting Abstracts. 2016. 1 indexed citations
9.
Wyber, Rosemary, Ben J. Boyd, Samantha Colquhoun, et al.. (2016). Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. Drug Delivery and Translational Research. 6(5). 572–578. 26 indexed citations
10.
Kløverpris, Henrik N., Akil Jackson, Amanda Handley, et al.. (2013). Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals. PLoS ONE. 8(10). e74389–e74389. 2 indexed citations
11.
Paige, D. A., J. P. Williams, Mark Sullivan, & B. T. Greenhagen. (2011). LRO Diviner Lunar Radiometer Global Mapping Results and Gridded Data Product. Lunar and Planetary Science Conference. 2544. 9 indexed citations
12.
Kløverpris, Henrik N., Anders Fomsgaard, Amanda Handley, et al.. (2010). Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hours. Journal of Immunological Methods. 356(1-2). 70–78. 38 indexed citations
13.
Rose, Robert De, Mark Sullivan, C. Jane Dale, et al.. (2006). Dose-Response Relationship of DNA and Recombinant Fowlpox Virus Prime-Boost HIV Vaccines: Implications for Future Trials. Human Vaccines. 2(3). 134–136. 11 indexed citations
14.
Rose, Robert De, C. Jane Dale, Jeanette C. Reece, et al.. (2004). Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques. Vaccine. 23(16). 1949–1956. 27 indexed citations
15.
Peters, Marion G., Hie‐Won Hann, Paul Martin, et al.. (2003). Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).. Gastroenterology. 126(1). 91–101. 440 indexed citations
16.
17.
Benhamou, Yves, Roland Tubiana, Vincent Thibault, et al.. (2002). Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV. Journal of Hepatology. 36. 138–138. 16 indexed citations
18.
Donald, M., R. Helm, J. Irwin, et al.. (2002). Localized chromaticity correction of low-beta insertions in storage rings. 131–133. 4 indexed citations
19.
DeBra, Daniel B., R. Farley, D. Gill, et al.. (1998). The telescope readout electronics for the Gravity Probe B satellite. Springer Link (Chiba Institute of Technology).
20.
Nevens, Frederik, Janice Main, Pieter Honkoop, et al.. (1997). Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study. Gastroenterology. 113(4). 1258–1263. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Pyo Hong Breakdown of academic impact, for papers by Christian M. Lange Breakdown of academic impact, for papers by Marija Zeremski Breakdown of academic impact, for papers by Hussein Hassan Aly Breakdown of academic impact, for papers by Soo Aleman Breakdown of academic impact, for papers by Virginie Morel Breakdown of academic impact, for papers by Mariantonietta Pisaturo Breakdown of academic impact, for papers by Enea Spada
Rankless by CCL
2026